About Aidan King
Aidan King is a director at Altay Therapeutics.
Experience
This experience comes from Aidan King's profile and from SEC filings. For roles taken from filings, the years are when the filings name Aidan King in the role, so the role may have started earlier or lasted longer.
Altay Therapeutics, Inc. Current
Director
2026 – Present · San Carlos, CA
Develops experimental drugs for people with muscular dystrophy, inflammatory diseases and cancer.
EG
EXCIVA GmbH Current
Board Member
2025 – Present
CP
Corteria Pharmaceuticals Current
Board Member
2022 – Present
XI
XyloCor Therapeutics, Inc. Current
Board Member
2021 – Present
FP
Fountain Healthcare Partners Current
Co-Founder and Managing Partner
2005 – Present
ET
Ermium Therapeutics
Board Member
2022 – 2024
ST
Syndesi Therapeutics
Board Member
2018 – 2022
VI
Velicept Therapeutics, Inc.
Board Member
2017 – 2020
CT
Chrono Therapeutics
Board Member
2014 – 2019
CT
Civitas Therapeutics
Board Member
2011 – 2015
PC
Palyon Medical Corporation
Board Member
2009 – 2015
BI
BIO-IB
Partner
2005 – 2007
EC
Elan Corporation
Vice President Corporate Business Development
1994 – 2004
Key Colleagues at Startups
The people Aidan King works with at each company, as listed on that company's latest Form D.
Altay Therapeutics, Inc. · Form D, Oct 2, 2026
James Breitmeyer
CEO and director
AO
Ali Ozes
Founder and CSO
EB
Eric Bjerkholt
Director
MG
Mike Grey
Executive Chair
Ester Sklarsky
Board Director
CJ
Chelsea Johnson
Director